Interestingly, immune surveillance is emerging as a key factor in SqCC ontogeny28, 36, with increased expression of PD-1, PD-L1, and CTLA-4 reducing immune surveillance in multiple tumour types12, 13, 36, 37, 38. The gene discussed is CTLA4; the disease is neoplasm.